Growth in Janus Henderson’s Biotech Hedge Fund driven by family offices
Janus Henderson’s biotechnology hedge fund has experienced a surge in demand, particularly among Asia-based family offices, driving the firm’s overall growth in the region, with assets jumping from $800m in November 2023 to over $2bn by September 2024, according to
